Metastases

Exercise Training in Women With Metastatic Breast Cancer

68Ga-PSMA PET in the Renal Cell Carcinoma

Zanidatamab in Combination With Pembrolizumab and Chemotherapy in HER2 and PD-L1 Positive Metastatic Gastroesophageal Adenocarcinoma (GEA) Patients

High Dose Radiotherapy for Palliation (Hi-D)

Preoperative Y-90 Radioembolization for Tumor Control and Future Liver Remnant Hypertrophy in Patients With Colorectal Liver Metastases

Malignant Pleural Disease Treated With Autologous T Cells Genetically Engineered to Target the Cancer-Cell Surface Antigen Mesothelin

Patterns of Care and Outcomes in METAstatic Soft Tissue SARComa

EpCAM-Targeted Surface-Enhanced Raman Spectroscopy Nanotags for Rapid Evaluation of Surgical Margins and Sentinel Lymph Node Metastasis Status in Breast Cancers

SABR PRIMER - Evaluating Stereotactic Ablative Radiotherapy for Primary and Regional Breast Tumors

Tumor-Targeted-NIR-II Fluorescent Molecular Probes for the Identification of Breast Cancer Tissue and SLN Metastatic Status

Everolimus After (Chemo)Embolization for Liver Metastases From Digestive Endocrine Tumors

Evaluation of Adjuvant Hormonal Treatment for 24 Months After Radical Prostatectomy in High Risk of Recurrence Patients.

QUILT-2.014: Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Longitudinal Study of Local Ablative Therapy in Oligometastatic Disease

68Ga-PSMA PET in the Prostate Cancer

Identification of Predictive and Prognostic Markers for Lung Cancer With Metastases

Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer

Evaluating Panitumumab (ABX-EGF) Plus Best Supportive Care Versus Best Supportive Care in Patients With Metastatic Colorectal Cancer

Panitumumab (ABX-EGF) Monotherapy in Patients With Metastatic Colorectal Cancer

PRISM (Panitumumab Regimen In Second-line Monotherapy of Head and Neck Cancer)